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To evaluate the clinical correlates and long-term prognostic 
significance of silent ischemia during exercise, 1,698 con- 
secutive symptomatic patients with coronary artery disease 
who had both treadmill testing and cardiac catheterization 
were studied. These patients were classified into three 
groups: Group 1 = patients with no exercise ST deviation 
(n = 856), Group 2 = patients with painless exercise ST 
deviation (n = 242) and Group 3 = patients with both 
angina and ST segment deviation during exercise (n = 600). 
Patients with exercise angina had a history of a longer 
and more aggressive angina1 course (with a greater fre- 
quency of angina, with nocturnal episodes and/or a pro- 
gressive symptom pattern) and more severe coronary ar- 
tery disease (almost two-thirds had three vessel disease). 
The 5 year survival rate among the patients with painless 
ST deviation was similar to that of patients without ST 
In patients with symptomatic, angiographically documented 
coronary artery disease, the degree and severity of angina1 
symptoms are correlated with prognosis (1). A number of 
recent studies (2-7) reported that many patients with symp- 
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deviation (86% and 88%, respectively) and was signifi- 
cantly better than that of patients with both symptoms and 
ST deviation (5 year survival rate 73% in patients with 
exercise-limiting angina). Similar trends were obtained in 
subgroups defined by the amount of coronary artery disease 
present. 
In the total study group of 1,698 patients, silent ischemia 
on the treadmill was not a benign finding (average annual 
mortality rate 2.8%) but, compared with symptomatic 
ischemia, did indicate a subgroup of patients with coronary 
artery disease who had a less aggressive angina1 course, less 
coronary artery disease and a better prognosis. Thus, silent 
ischemia during exercise testing in patients with sympto- 
matic coronary artery disease represents an intermediate 
risk response in the spectrum of exercise-induced ischemia. 
(J Am Co11 Cardiol1989;14:885-92) 
tomatic coronary disease also have painless episodes of 
myocardial ischemia. In an early study, Maseri (8) showed 
that angina1 symptoms were a late and inconsistent finding 
during ischemic episodes in patients with variant angina, 
even when the ischemia was transmural and severe. A more 
recent investigation (9) found that symptoms occur well after 
the onset of objective signs of ischemia in patients undergo- 
ing transient coronary occlusion by balloon inflation during 
coronary angioplasty. These reports have raised important 
questions about the reliability of angina as a marker of 
myocardial ischemia. 
It is now well known that some patients with sympto- 
matic coronary disease demonstrate painless ST segment 
deviation during an exercise test, but the prognostic signifi- 
cance of this finding relative to symptomatic ST deviation 
remains uncertain (6). In particular, it is unclear whether the 
failure to experience symptoms during exercise-induced 
ischemia represents a specific marker for an increased risk of 
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subsequent cardiac events. Previous work from our grow;, 
(10) suggested that exercise-induced ischemia spans the 
prognostic continuum from no ischemia (low risk) to marked 
ST deviation accompanied by exercise-limiting angina (high 
risk). The purpose of the present study was to describe the 
clinical characteristics and long-term prognosis of a large 
group of symptomatic patients with documented coronary 
artery disease and painless exercise ST deviation (“silent 
ischemia”) and to relate their clinical features and prognosis 
to the larger group of patients with symptomatic coronary 
artery disease referred for exercise testing and cardiac 
catheterization. 
Methods 
Study patients. All patients undergoing cardiac catheter- 
ization at Duke University Medical Center between Novem- 
ber 1969 and January 1981 for evaluation of chest discomfort 
or equivalent symptoms suggesting coronary artery disease 
were identified. Patients with significant valvular or congen- 
ital heart disease or previous cardiac surgery were excluded. 
Of the 4,730 patients meeting these initial criteria, 1,698 had 
significant coronary artery disease (~75% stenosis) and 
underwent a Bruce protocol treadmill test within 6 weeks of 
cardiac catheterization. This total excludes patients whose 
treadmill test was uninterpretable because of rest or exer- 
cise-induced left bundle branch block or technical problems, 
as well as patients whose only exercise ST changes consisted 
of ST elevation in electrocardiographic (ECG) leads with 
pathologic Q waves (10). 
The study patients were class$ed into three groups on 
the basis of results of their treadmill test: Group 1 = patients 
with no exercise ST deviation (n = 856), Group 2 = patients 
with painless exercise ST deviation (n = 242) and Group 3 = 
patients with both angina and ST deviation during exercise 
(n = 600). Patients in Group 3 were further classified into 
those with nonlimiting exercise angina (n = 320) (Group 3A) 
and those with exercise-limiting angina (n = 280) (Group 3B) 
because previous work from our institution (10) had shown 
that this distinction was prognostically important. 
Information system. The computerized medical informa- 
tion system used in this study has been described previously 
(11, 12). In brief, a cardiac history, physical examination, 
chest radiograph and 12 lead ECG at rest were obtained 
prospectively on all patients at the time of catheterization 
and entered into a computerized data base. Similarly, the 
results of the exercise treadmill test and cardiac catheteriza- 
tion were entered prospectively into the system. 
Definitions of the major clinical and catheterization var- 
iables used in this study have been published previously 
(1,12). The patients’ symptoms were characterized either as 
typical for angina or as having one or more atypical features 
(1). The angina1 pain course of each patient was classified as 
either stable or progressive (but not unstable); patients with 
unstable angina were not referred for exercise testing and, 
hence, were not included in this study. 
Follow-up. All patients were followed up by clinic visit, 
mailed questionnaire or telephone interview at 6 months and 
1 year after catheterization and yearly thereafter (12). Over- 
all, follow-up was 98% complete at all intervals. At each 
patient contact, vital status was ascertained and details of 
interval hospitalizations were recorded. Standard ECG and 
enzyme criteria were used for diagnosis of a subsequent 
myocardial infarction, as previously described (13). The 
median follow-up period for the study group at the time the 
data analysis file was created was 5 years, and 10% have 
been followed up for ~10 years (10). 
Exercise treadmill test. All study patients underwent a 
standard Bruce protocol treadmill exercise test, as previ- 
ously described (10,14). All studies during the 11 year study 
period were supervised by the same chief laboratory techni- 
cian. Twelve ECG leads were recorded before exercise, at 
the end of each exercise stage, at peak exercise and at 2 
minute intervals during recovery. During exercise, three or 
four standard ECG leads were continuously monitored. 
Exercise was continued until limiting symptoms, abnormal- 
ities of rhythm or blood pressure or marked and progressive 
ST displacement developed (10). Any exercise or postexer- 
cise ST displacement of ~0.1 mV compared with the rest 
tracing that was horizontal or sloping away from the baseline 
at 0.08 s after the J point was measured to the nearest 0.05 
mV with a calibrated grid. Exercise-induced angina was 
defined as symptoms during the test that were typical for 
angina pectoris or that mimicked the patient’s presenting 
symptoms. The symptoms were termed exercise-limiting if 
the angina was the primary reason the patient stopped 
exercising. The decision to discontinue cardiac medications 
before the exercise test was made by the patient’s attending 
physician. Fifty-eight percent of patients had taken propran- 
0101 within 48 h and 13% had taken digoxin within 1 week of 
the test. 
Cardiac catheterization. Coronary angiography was per- 
formed within 6 weeks of the exercise test in multiple 
oblique and angulated projections. Results were reviewed by 
at least two senior angiographers on the day of catheteriza- 
tion, as previously described (12). Significant coronary ar- 
tery disease was defined as ~75% luminal diameter narrow- 
ing of a major coronary artery. Left ventricular ejection 
fraction was calculated using the modified area-length 
method. 
Data analysis. Kaplan-Meier estimates were used to gen- 
erate survival curves from the day of cardiac catheterization 
(15). For survival curves of patient subgroups, rates were 
not calculated beyond the point in the follow-up period when 
<15 patients remained at risk. All patients were considered 
to be initially treated nonsurgically. The follow-up of 664 
patients (39%) undergoing coronary bypass graft surgery 
was included up to the date of their operation; these patients 
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Table 1. Clinical and Catheterization Data in 1,698 Patients 
Exercise-Induced ST Segment Deviation 
With Nonlimiting With Exercise- 
None Painless Exercise-Induced Limiting Angina 
(Group 1) (Group 2) Angina (Group 3A) (Group 38) 
Characteristic (n = 856) (n = 242) (n = 320) (n = 280) 
Discrete variahles 
Male (R) 79 83 9t0 91 
Diabetes (% I I? 9 x IO 
Hypertension (7~) 36 34 33 36 
Smoking (%I 74 71 73 71 
History of MI (%I 46 40 39 44 
Q wave Ml I%) 35 35 33 35 
Resting ECG ST 38 42 46 41 
changes (‘ic) 
One vessel CAD (%) 38 21 I3 II 
Two vessel CAD (%) 31 31 29 26 
Three vessel CAD (%) 31 48 5x 63 
Left main CAD (%) 4 I? IO I4 
Proximal LAD CAD (%I 39 42 53 59 
Continuous variables* 
Age (yr) 44149155 46153159 46152158 46153158 
Ejection fraction (c/o) 4615616 1 46155160 46155160 45154160 
*Data presented as 25th percentileimediani75th percentile. CAD = coronary artery disease: ECG = electrocar- 
diographic; LAD = left anterior descending: MI = myocardial infarction. 
were then withdrawn (that is, censored) from the survival 
calculations. The median interval from catheterization to 
surgery in surgically treated patients was 4 weeks, and only 
2% of patients had their operation later than 6 months. The 
results of this study were unchanged when the surgically 
treated patients were excluded from the total study group. 
Continuous variables were summarized with medians and 
quartile ranges (25th to 75th percentiles). Baseline differ- 
ences among Groups 2, 3A and 3B were tested using the 
chi-square test for discrete variables and the Kruskal-Wallis 
one-way analysis of variance for continuous variables. 
Breslow’s formulation of the Cox proportional hazards re- 
gression model was used to test the association of exercise 
angina with the time to cardiovascular death (16-18). 
Results 
Patient characteristics. The baseline clinical, catheteriza- 
tion and exercise test variables for the study patients are 
shown in Tables I to 3. There was a somewhat higher 
prevalence of men among patients with exercise angina 
(Groups 3A and 3B) than among patients without exercise 
angina (Group 2) (p = 0.02), but most other clinical baseline 
characteristics did not differ among these patient groups. In 
particular, the prevalence of diabetes was similar in the three 
groups (Table 1). 
Angina history. All study patients, by design, had chest 
discomfort or equivalent symptoms that had prompted their 
referral for exercise testing and cardiac catheterization. 
Several angina1 characteristics from the clinical history 
showed a clear gradient among the three patient groups with 
exercise ST deviation (Table 2). Thus, typical angina pecto- 
ris was found in 61% of patients without exercise-induced 
angina (Group 2), whereas it was present in 87% of patients 
with exercise-limiting angina (Group 3B) (p < 0.001). A 
progressive angina1 course was found in only 22% of Group 
2 patients, whereas 51% of Group 3B patients had had an 
increase in the frequency, severity or duration of their 
angina1 episodes in the previous 6 weeks (p < 0.001). One or 
more nocturnal episodes of angina in the previous 6 weeks 
was reported by 24% of Group 2 patients and 46% of Group 
3B patients (p < 0.001). Group 2 patients had a median 
frequency of 3 angina1 episodes/week compared with a 
Table 2. Clinical Angina1 Variables* in the Four Clinical Groups 
Characteristic Group 1 Group 2 Group 3A Group 3B 
Typical angina (%,) 
Progressive angina (i;;) 
Nocturnal angina (?I) 
Angina frequency++ 
Duration of angina1 
symptoms (months)+ 
55 61 84 87 
35 22 37 51 
40 24 35 46 
215114 11317 217114 4110/20 
5116152 5114145 61 I Y/60 10135174 
*Variables in this table are all obtained from the patients’ clinical history. 
Exercise data are presented in Table 3. tData presented as 25th percentile/ 
mediani75th percentile. *Episodes per week. 
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Table 3. Exercise Test Data in the Four Clinical Groups 
Characteristic Group 1 Group 2 Group 3A Group 3B 
ST deviation (mV)* 
ST elevation only (%) 
Downsloping ST 
depression (%) 
Peak exercise heart 
rate (beats/min)* 
Exercise duration 
(min)* 
Exercise angina (%) 
- 0.125/0.175/0.250 0.15010.20010.250 0.125/0.175/0.250 
- 7 6 5 
- 34 47 53 
120/140/146 120/135/144 112/130/140 110/130/137 
416.519 41619 31518 314.516.5 
51 0 100 IO0 
*Data presented as 25th percentile/median per 75th percentile. 
median of 10 episodes/week in patients in Group 3B (p = 
0.0001). The median duration of angina1 symptoms was 14 
months for Group 2 and 35 months for Group 3B (p = 
0.0001). 
Other baseline characteristics. Cardiac catheterization 
showed that patients with exercise-induced angina and ST 
deviation were more likely to have three vessel coronary 
artery disease than were patients with painless exercise ST 
deviation (p = 0.003) (Table 1). In contrast, left ventricular 
function, as judged by the left ventricular ejection fraction, 
did not differ among the groups. 
The median amount of ST deviation observed was the 
same in Groups 2, 3A and 3B, although patients with 
exercise-induced angina (Groups 3A and 3B) had a higher 
prevalence of downsloping ST depression than did the 
patients with silent ischemia (Group 2) (Table 3). In addition, 
patients with exercise-induced angina had a shorter exercise 
time (p = 0.0005) and lower peak exercise heart rate (p = 
0.0002) than did patients with silent ischemia. 
Fifty-one percent of the patients without exercise-induced 
ST deviation (Group 1) had exercise-induced angina. Most 
baseline characteristics of these patients were not signifi- 
cantly different from those of the patients with exercise- 
induced ST deviation only (Group 2). The subgroup of 
Group 1 patients with exercise-induced angina, however, 
demonstrated a higher prevalence of progressive angina1 
symptoms (41% versus 22%) and nocturnal episodes (43% 
versus 24%) and a higher median angina1 frequency (seven 
versus three episodes per week) than those of Group 2 
patients, whereas Group 2 patients had more severe coro- 
nary artery disease (48% had three vessel disease versus 
37% for Group 1 subgroup). Group 1 patients without 
exercise-induced angina also had baseline characteristics 
that were largely similar to those in the silent ischemia 
group. In this subgroup, however, there was a lower preva- 
lence of men (76% versus 83% for Group 2) and less severe 
coronary artery disease (27% with three vessel disease 
versus 48% for Group 2). 
Long-term prognosis. The survival and infarction-free 
survival curves for up to 10 years of follow-up in Groups 1 to 
3 are shown in Figures 1 and 2, respectively. Patients 
without exercise-induced ST changes (Group 1) had a similar 
prognosis whether or not angina was induced during exercise 
(Cox model, $ = 1.7, p = 0.19). The patients with painless 
exercise ST deviation (Group 2) had a slightly worse long- 
term prognosis than did patients without exercise ST devia- 
tion (Group I), although the difference was not statistically 
significant. In addition, the prognosis of Group 2 patients 
was not significantly different from that of the subgroups of 
Group 1 patients defined according to the presence or 
absence of exercise-induced angina. 
In contrast, the prognosis of Group 2 patients was 
significantly better than that of either of the two patient 
groups with exercise ST deviation and exercise-induced 
angina (Groups 3A and 3B). For Groups 1 and 2, the 5 year 
survival rates were 88% and 86%, respectively, whereas for 
Groups 3A and 3B patients, the corresponding survival 
figures were 77% and 73%, respectively. The 5 year infarc- 
tion-free survival rates for Groups 1 and 2 were 78% and 
78%, respectively, and the corresponding infarction-free 
Figure 1. Survival probabilities for the four clinical groups (see text) 
for up to 10 years of follow-up. Shown below the x axis are the 
number of medically treated patients at each follow-up point. N = 
number of patients. 
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Figure 2. Infarction-free survival probabilities for the four clinical 
groups (see text). 
survival rates for Groups 3A and 3B were 68% and 64%, 
respectively. The survival rate for the patients with painless 
exercise ST deviation was signficantly better than that for 
patients with both exercise-induced angina and ST deviation 
(Groups 3A and 3B) (Cox model, ,$ = 9, p = 0.003). After 
using the Cox model to adjust for the baseline imbalances in 
the extent of coronary artery disease, however, survival 
differences among these three groups became only margin- 
ally significant (,$ = 3.5, p = 0.06). In contrast, the survival 
rate for patients with painless ST deviation (Group 2) was 
not significantly different from that for patients without 
exercise ST deviation (Group 1) (Cox model, /J = 0.7, p = 
0.40). 
Prognostic subgroups. These overall prognostic trends 
were also found in subgroups defined by the extent of 
coronary artery disease present. Thus, in the study patients 
with three vessel disease, the 5 year survival rate for Group 
2 patients was 75% compared with 66% and 69%, respec- 
tively, for Groups 3A and 3B. 
None of these results were significantly altered when the 
patients referred for coronary artery bypass surgery were 
excluded from the study or when these analyses were 
repeated in the subgroup of patients who were not taking any 
antianginal medication at the time of their exercise test. 
When the total study group was subgrouped according to 
whether their angina1 course was considered to be stable or 
progressive, the tendency persisted for the symptomatic 
patients with ischemia (Groups 3A and 3B) to have a worse 
prognosis than the patients with silent ischemia (Group 2). A 
formal test of the difference in prognosis among Groups 2, 
3A and 3B after adjusting for the angina1 course (stable 
versus progressive) with the Cox model showed that these 
differences remained significant (,$ = 6, p = 0.01). Finally, 
the results were unchanged when the analysis was restricted 
to patients with pure effort angina by history. 
Discussion 
Prognostic importance of silent iscbemia. The most impor- 
tant finding of this study is that painless ST deviation during 
a treadmill exercise test (“silent ischemia”) in patients with 
symptomatic coronary artery disease does not identify a 
uniquely high risk subgroup of patients with a “positive” 
exercise test. Rather, our data support the conclusion that 
the more evidence of ischemia these patients develop during 
exercise, as reflected by both subjective and objective 
measures, the worse their prognosis. This result comple- 
ments our previous finding (1) that in symptomatic patients 
with coronary artery disease, the more frequent or progres- 
sive the angina1 symptoms, the poorer the prognosis. 
Clinical correlations of silent ischemia. This study con- 
firms and extends the results of several previous studies (19, 
20) that reported differences in clinical characteristics be- 
tween patients with and without exercise angina. Both the 
Coronary Artery Surgery Study (CASS) group (20) and 
Falcone et al. (19) found that patients with exercise-induced 
angina were more often in New York Heart Association 
functional class III or IV than were patients without exercise 
angina. In our study, patients with symptomatic exercise ST 
deviation had a higher prevalence of typical angina1 symp- 
toms and a more progressive angina1 course than had pa- 
tients with silent ischemia. In contrast, no differences were 
found in the prevalence rates for diabetes, hypertension or 
smoking history. Two small studies (21,22) previously de- 
scribed an association of diabetes with painless exercise- 
induced ischemia, whereas several studies (19,23,24) in 
addition to ours have not found such an association. 
Angina during exercise testing was associated in this 
study with a significantly higher prevalence of three vessel 
coronary artery disease, and almost two-thirds of patients 
who stopped exercise because of angina had three vessel 
disease. The CASS investigators (20) reported a similar 
trend, whereas other small studies (21,23) reported a positive 
but nonsignificant association in this direction. In contrast, 
neither we nor other investigators have found any difference 
in left ventricular ejection fraction at rest between patients 
with and without exercise angina. 
We found that patients with coronary disease who de- 
velop exercise-induced angina have a shorter exercise dura- 
tion and lower peak heart rate than do patients without 
exercise angina (Table 3), in agreement with previous inves- 
tigators (19,23,24). In contrast, angina during exercise was 
not associated with a difference in the observed degree of 
exercise-induced ST deviation, although the symptomatic 
patients had their maximal ST deviation at lower work loads 
and had a higher prevalence of downsloping ST depression. 
Thus, the clinical correlates of symptomatic exercise- 
induced ischemia (Group 3) relative to siletzt exercise isch- 
emia (Group 2) in our study patients were a higher preva- 
lence of factors associated with more severe coronary artery 
disease (that is, more men, more typical symptoms, a longer 
duration of symptoms) and with a worse prognosis (that is, 
more progressive angina1 course with more frequent symp- 
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toms and nocturnal episodes, and exercise ST deviation at a these subjects in the CASS studies may account for some of 
lower work load) (1 ,lO, 14,25). the differences with our study. 
Prognostic comparisons. To appreciate the prognostic 
significance of painless ST deviation on the treadmill, pa- 
tients with this finding must be viewed in context. In our 
study, which deals only with patients referred for evaluation 
of symptomatic coronary artery disease (Cohn’s type III 
silent ischemia) (7), we employed two comparison groups- 
patients with no exercise ST deviation (Group 1) and pa- 
tients with symptomatic exercise ST deviation (Group 3). 
Our results show that painless exercise ST deviation identi- 
fies a group of patients with an average annual mortality rate 
of about 2.8%. This was not significantly different from that 
in patients with coronary artery disease without exercise ST 
deviation overall (Group 1) or from subgroups of this group 
defined by the presence or absence of exercise-induced 
angina (average annual mortality rate 2.8% and 2.5%, re- 
spectively), but was significantly better than the prognosis of 
patients with symptomatic ischemia (average annual mortal- 
ity rate for Group 3B patients 5.4%). 
In contrast to the observational CASS reports, angina 
was the only exercise variable that identified CASS random- 
ized patients who had an improved prognosis with surgical 
therapy (29). Because the treatment groups were balanced 
by randomization, the prognostic importance of exercise- 
induced angina in this subset of patients cannot be explained 
by varying amounts of coronary artery disease. 
Comparison with other studies. These results are different 
from those reported by Weiner et al. (20,25) in the Coronary 
Artery Surgery Study (CASS). The CASS patients with 
silent ischemia had a significantly worse prognosis than did 
patients without any exercise-induced ischemia (angina or 
ST depression). On the other hand, there was no significant 
survival difference in the CASS study among patients with 
exercise angina only, patients with silent ischemia and 
patients with both exercise-induced angina and ST depres- 
sion, despite a higher prevalence of three vessel disease in 
the latter group (20). An earlier and smaller study by Weiner 
et al. (26) found that exercise-induced angina was predictive 
of multivessel disease and that the combination of ischemic 
ECG changes and exercise-induced angina was more predic- 
tive than was either response alone. Another early study by 
Cole and Ellested (27) reported that patients with exercise- 
induced angina and ST depression had a worse prognosis 
than did those with ST depression alone. 
Recently, the CASS investigators (28) presented prelim- 
inary data suggesting that silent ischemia patients with three 
vessel disease actually have a significantly worse prognosis 
than do patients with symptomatic ischemia and three vessel 
disease. No such trend was evident in our data. 
Most of the other prognostic studies of silent exercise- 
induced ischernia in patients with symptomatic coronary 
artery disease have been relatively small, with the conse- 
quence that their statistical power was too low to detect 
survival differences in multiple subgroups. Falcone et al. (19) 
followed up 473 patients with documented coronary artery 
disease and an ischemic ST response during bicycle exercise 
for an average of r3 years. They observed no difference in 
coronary anatomy or long-term prognosis between patients 
with silent and symptomatic exercise-induced ischemia. 
Bonow et al. (30) followed up 131 consecutive patients with 
coronary artery disease and mild or no symptoms for an 
average of 5 years. The prevalence of three vessel or left 
main coronary artery disease was significantly higher in their 
patients with exercise-induced angina than in those without 
it. Only five deaths occurred during the follow-up period, 
however, and all occurred in patients with three vessel 
disease who had both exercise-induced ST depression and a 
decrease in radionuclide left ventricular ejection fraction 
during exercise. Thus, exercise-induced angina added no 
prognostic information to those objective markers of isch- 
emia in their study. Assey et al. (23) reported a marginally 
significant increase in the number of myocardial infarctions 
observed during follow-up study of 27 patients with silent 
ischemia relative to 28 patients with symptomatic ischemia 
but observed no differences in the death rates between the 
two groups. Interpretation of their study is difficult because 
the investigators did not analyze their data using a method 
that took unequal or incomplete follow-up times into account 
(such as life tables or Cox model). 
One potentially important difference between ourfindings 
and the CASS results is that 35% of the patients in the latter 
study with silent ischemia and 7% of their patients with 
symptomatic ischemia had no clinical history of angina; most 
of those patients were presumably studied after myocardial 
infarction. In our study, all patients had a history of angina 
and the prevalence of prior myocardial infarction was lower 
in each group.Because the relative prognostic importance of 
exertional angina and exercise-induced ST deviation may be 
different in asymptomatic patients with recent myocardial 
infarction than in patients with stable angina, inclusion of 
Classification of silent ischemia. The optimal prognostic 
classification scheme for silent ischemia remains unclear. 
Cohn’s classification (7) is based on broad clinical groupings 
and is not oriented toward prognostic stratification of indi- 
vidual patients. Maseri (8) seperated patients with coronary 
artery disease pathophysiologically into those with increased 
myocardial oxygen demand (for example, angina only on 
effort), those with decreased myocardial oxygen supply (for 
example, variant angina, unstable angina) and those with a 
mixed mechanism of ischemia. The more a patient moves 
toward the decreased oxygen supply side of this scheme (for 
example, progressive symptoms with rest or nocturnal epi- 
sodes), the worse the prognosis, at least over the short-term 
(1,31). According to this formulation, the prognostic impor- 
tance of silent as well as symptomatic ischemic episodes 
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detected by exercise testing should differ from that of 
ischemic episodes detected by ambulatory ECG monitoring. 
Exercise testing, usually done in patients with stable symp- 
toms, is designed to detect (albeit indirectly) flow-limiting 
coronary stenoses, whereas rest episodes of ischemia are 
believed to connote an active (and potentially unstable) local 
coronary arterial environment (such as a fissured atheroscle- 
rotic plaque). 
Because of concerns that our results might have been 
affected by pooling patients with a clinical history of 
“mixed” angina and those with effort only angina, we 
repeated our prognostic analyses subgrouping the latter 
patients. This subgrouping had no significant effect on our 
results, suggesting that symptomatic classification of pa- 
tients according to the previously described pathophysio- 
logic scheme does not affect the prognostic importance of 
silent relative to symptomatic exercise-induced ischemia. It 
remains to be determined, however, whether a classification 
scheme based on some combination of symptoms and am- 
bulatory ECG monitoring would provide a more accurate 
and prognostically useful approach. 
Limitations. Several important limitations of our study 
should be recognized. First, all our patients were referred for 
cardiac catheterization. and results different from ours might 
be observed in outpatient groups. Without confirmation by a 
second test such as coronary angiography, however. it is 
impossible to distinguish “ischemic” exercise-induced ST 
deviation in patients with coronary artery disease from 
“false positive” ST changes in patients without significant 
obstructive coronary artery disease. Second, our study 
included only patients referred for symptoms, and no direct 
extrapolation can be made to patients who are totally asymp- 
tomatic (Cohn’s type 1) (7). Similarly, care must be taken in 
extending our results to patients with silent ischemia after a 
symptomatic myocardial infarction (Cohn’s type 2). Finally, 
it is possible that our results could be affected by differential 
rates of referral to coronary bypass surgery. Referral to 
surgery was more likely in the patients with exercise- 
induced angina, however, so it seems likely that referral to 
surgery may, if anything, have reduced the true prognostic 
difference between silent and symptomatic ischemia sub- 
groups. 
Conclusions. Patients with symptomatic coronary artery 
disease with silent exercise-induced ischemia do have a 
moderate risk of coronary events (average annual mortality 
rate 2.8%), but relative to patients with symptomatic isch- 
emia, they have a less aggressive angina1 course, less severe 
coronary artery disease and consequently a better prognosis. 
Prognostic stratification in this group of patients was im- 
proved by considering both subjective and objective markers 
of ischemia. Furthermore, this study does not support the 
concept that exercise-induced silent ischemia in patients 
with symptomatic coronary artery disease has unique ad- 
verse prognostic consequences. 
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